Recent evidence suggests that platelets are not only involved in haemostatic processes but also modulate immune responses. As antigen-presenting cells (APC) are of crucial importance for the regulation of immunity, in this study we wanted to define the role of platelet factor 4 (PF-4) as one of the major platelet-derived chemokines on the transition of monocytes into APCs. Our experiments show that within 3 days PF-4 in conjunction with IL-4 induces a rapid differentiation of monocytes into APC. These PFAPC (PF-4/IL-4 differentiated APC) display unique phenotypical and functional characteristics setting them apart from macrophages and conventional dendritic cells. Functional studies revealed that PFAPC preferentially stimulated proliferation of lymphocytes and lytic NK activity while they induced only moderate cytokine responses. Beyond day 3 of differentiation, PFAPC became less immunostimulatory and maintained their capacity to phagocytose particulate material even after LPS-induced maturation. These experiments uncover a previously unknown role for the platelet-derived CXC-chemokine PF-4 in differentiation of human APC. Our data further support the newly discovered function of platelets in immunomodulation and provide new evidence for a rapid transition of monocytes into APC under the influence of inflammatory stimuli. The first and main function of platelets at sites of acute trauma or injury is to stop blood loss and form a matrix that facilitates the recruitment of other immune cells as well as tissue remodeling. In addition, platelets themselves secrete a variety of mediators that direct the influx and modulate the function of various immune cells. Upon activation, platelets release the contents of their α- granules and secrete growth factors, cytokines, and chemokines. Vascular endothelial growth factor (VEGF) and platelet-derived growth factor (PDGF) promote the recruitment of endothelial cells, monocytes, and other leukocyte subpopulations (3). Influx of these immune cells is further sustained by the release of chemokines. β-Thromboglobulin antigens (CXCL7) and platelet factor 4 (PF-4, CXCL4) are the major platelet-derived CXC chemokines involved in this process (4). Unlike other CXC chemokines, which effect only a limited set of target cells, PF-4 acts on a large variety of different immune cells including basophils (5), T-cells (6), and NK cells (7). Of particular importance for the data presented in this study is our recent observation that PF-4, similar to GM-CSF and M-CSF, inhibits spontaneous apoptosis of monocytes and induces differentiation of monocytes into macrophages. Although these macrophages secrete substantial amounts of TNF-α and express high amounts of the macrophage marker carboxypeptidase M, their expression of HLA-DR is low or absent (8).
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Interleukin-4 (IL-4) is a major T H 2-cytokine and by acting on the T-cell level of crucial importance for the outcome of adaptive immune responses. In addition, it also modulates the differentiation and function of antigen-presenting cells (APC; 9, 10) . This has led to a major breakthrough in the field of dendritic cell (DC) biology, as IL-4 together with GM-CSF is able to promote the in vitro differentiation of human peripheral blood monocytes into DCs (refs 11, 12) . Although the development and differentiation of DCs in vivo are far from being understood and still a matter of intensive debate (13) , there is emerging evidence for a generation of DCs from monocyte precursors also in vivo. This evidence is based on the observation of DC development under pathological conditions (14, 15) , ex vivo models (16) , and in vitro models resembling physiological conditions (17) (18) (19) . However, the exact conditions under which monocyte to DC transition in vivo might occur are still largely elusive. Nevertheless, the available experimental data suggest that the time kinetics of human DC differentiation under physiological conditions is not adequately reflected by current in vitro protocols for DC generation. Thus, it has been shown that DCs can spontaneously emerge from certain monocyte subsets after ex vivo isolation and overnight culture (16) . In a model of transendothelial trafficking, phagocytosing monocytes differentiate within 2 days to become migratory DCs (17) and the pro-inflammatory cytokine interferon-α seems to be involved in rapid monocyte to DC differentiation in vitro (20) and in vivo (14) .
As the possible mediators that might be involved in this generation of DCs under normal, pathological, or inflammatory conditions are only beginning to be elucidated (14, 20) , we hypothesized that the cooperative action of the platelet-derived chemokine PF-4 and the cytokine IL-4 would induce differentiation of monocytes into professional APC. To study this, we differentiated human monocytes for up to 7 days in the presence of PF-4 and IL-4 and assessed various phenotypical and functional characteristics of these differentiated cells. We can show that a combination of PF-4 and IL-4 indeed induces differentiation of human monocytes into professional APCs and modulates the function of these cells. Resulting PFAPCs were clearly distinct from conventional DC and macrophages. Functional analyses revealed that PFAPCs induced substantial proliferation of lymphocytes and cytotoxicity of NK cells whereas they provoked only modest cytokine responses when compared with conventional DCs as a reference APC population. Thus, our experiments describe PFAPC as a population of specialized APC distinct from conventional DCs and macrophages. These findings further advance our understanding of monocyte differentiation under the influence of inflammatory stimuli.
MATERIALS AND METHODS

Antibodies, cytokines, and reagents
The mAb directed against CD1a-phycoerythrin (-PE) was bought from Immunotech (Marseille, France), and mAb CD209 was obtained from eBioscience (Biocarta, Hamburg, Germany). CD14-PE and CD86-PE mAbs were purchased from Dianova (Hamburg, Germany). CD1b/c and CD40-PE were purchased from Biosource (Camarillo, CA). CD83 was obtained from PharMingen (San Diego, CA). MHC class II-PE and IgG2a-PE were from BeckmanCoulter (Fullerton, CA), and CCR7-PE was from RnDSystems (Minneapolis, MN). IgG1-PE and goat anti-mouse PE were obtained from DAKO (Glostrup, Denmark). Antibodies against BDCA1 and BDCA3 were from Miltenyi Biotec (Bergisch Gladbach, Germany). Recombinant human GM-CSF, IL-4, and soluble CD40L were purchased from TEBU/PeproTech (Offenbach, Germany). Recombinant human IFN-γ was kindly provided by Dr. Bertholt Thomae (Bieberach, Germany). Human natural PF-4 was purified to homogeneity from release supernatants of thrombinstimulated platelets in a three-step procedure as described previously (21) and determined by LAL-assay as essentially endotoxin free. Human serum (HS) was obtained from AB + donors and supplied by Institute of Immunology and Transfusion medicine, University of Lübeck.
RPMI 1640 (Gibco; Karlsruhe, Germany), supplemented with 10% heat-inactivated fetal calf serum (FCS, Linaris; Bettingen, Germany), L-glutamine (2 mM), penicillin (100 U/ml), and streptomycin (100 µg/ml), was used as the complete culture medium (R xx 10). 
Cell differentiation
PBMCs from heparinized blood of healthy donors were prepared by Ficoll-Paque ® (Biochrom; Berlin, Germany) separation method essentially as described by Bøyum (22) . Monocytes and lymphocytes were then separated by counter flow elutriation centrifugation from PBMCs (23) . Purity of fractions was >98% as determined by light scatter analysis using a CASY TT Schärfe (Reutlingen, Germany).
Immature human DC were generated according to Sallusto and Lanzavecchia (12) . In brief, monocytes were cultured for up to 7 days in R xx 10 supplemented with GM-CSF (500 U/ml) and IL-4 (500 U/ml), exchanging half of the medium including cytokines every 2-3 days. Macrophages were differentiated from monocytes in R xx 10 containing GM-CSF (500 U/ml) for up to 7 days. PF-4 macrophages were differentiated for up to 7 days from monocytes in R xx 10 with PF-4 (4 µM). PFAPCs were obtained by culturing monocytes in R xx 10 supplemented with PF-4 (4 µM) and IL-4 (500 U/ml) with half medium including IL-4 replaced every 2-3 days.
Note that for differentiation of classical DCs GM-CSF was added to the culture medium with every exchange of medium, while PF-4 was only given as an initial pulse treatment in the beginning of the differentiation period. In control studies, no phenotypical or functional differences were observed when PF-4 was also added during medium exchange.
For flow cytometric analysis, APC were stimulated with BCG (strain Connaught) for 3 days with a MOI of 1, LPS (Salmonella minnesota) in a concentration of 10 ng/ml, or soluble CD40L (1 µg/ml) in combination with IFN-γ (1000 U/ml) unless indicated otherwise.
Flow cytometric analysis
APCs were stained with fluorochrome-conjugated mAbs in PBS-5%HS, washed, fixed with 1.5% paraformaldehyde, and analyzed on a FACSCalibur using the CellQuest program (BectonDickinson, San Jose, CA). Data analysis was done using WinMDI 2.8 (by Joseph Trotter, Scripps Institute).
Cytokine assays
The concentration of TNF-α in the supernatants was determined by use of a quantitative enzyme-linked immunosorbent assay (ELISA), provided by Dr H. Gallati (Intex, Muttenz, Switzerland) and performed as recommended by the manufacturer. IFN-γ and IL-10 in the culture supernatants were determined by OptEIA™ Human ELISA kits (PharMingen; San Diego, CA) according to the instructions of the manufacturer. IL-12 was determined with the eBioscience Human IL-12p70 ELISA Ready-SET-Go! Kit from Biocarta. 
Mixed leukocyte reaction (MLR)
Antigen presentation assay
In a total volume of 100 µl per well, 2 × 10 5 autologous lymphocytes were seeded into 96-well round-bottom plates; 2 × 10 4 APC/well were added to give final ratios of 1:10 APC:Ly cells and incubated in presence and absence of TT (5 LF/ml) for 4 days in a final volume of 200 µl. To measure lymphocyte proliferation, [ 3 H]thymidine was added on day 3 at 1 µCi/well and incubated for an additional 18 h. Cells were then harvested, and the incorporation of [ 3 H]thymidine was determined in a scintillation counter (24) .
Cytokine production
Monocytes were seeded in R xx 10 into 24-well plates in a final volume of 750 µl at a concentration of 2 × 10 6 cells/ml. Cells were either cultured in the presence of GM-CSF (500 U/ml) and IL-4 (500 U/ml) or PF-4 (4 µM) and IL-4 (500 U/ml). Stimulation of cells with log phase BCG (MOI=1), LPS (10 ng/ml), or 3T3 fibroblasts overexpressing CD154 (25) was done on days 3 or 7. Supernatants were harvested 24 h later and analyzed for TNF-α, IL-10, and IL-12 by ELISA.
Oxygen radical formation and phagocytosis
Generation of reactive oxygen species by phagocytes was determined in a microplate luminometer (LB 96V, Berthold, Wildbad, Germany) by measurement of chemiluminescence in the presence of 90 µg/ml lucigenin (9,9'-bis-N-methylacridiniumnitrate, Roche Diagnostics) as described essentially elsewhere (26) . Briefly, cells (10 6 /ml) in CL-medium (RPMI 1640 buffered with 25 mM HEPES without phenolred, Biochrom) supplemented with lucigenin were distributed in 200 µl aliquots in an intransparent 96-well microtiterplate (Nunc, Wiesbaden, Germany) and preincubated for 60 min at 37°C. After stimulation with latex beads, (7.5×10 6 particles, Serva, Heidelberg, Germany) chemiluminescence was recorded for 60 min. Data are expressed as relative light units (RLU) and represent 60 min integrals of the respective time kinetics.
For measurement of unspecific phagocytosis, 2 × 10 5 cells were resuspended in 300 µl CLmedium and preincubated for 60 min at 37°C followed by addition of 2 × 10 6 FITC-conjugated mono-disperse latex beads (1.83 µm diameter, Polyscience Inc., Eppelheim, Germany). Beads were sedimented on the cell layer by centrifugation (1 min, 300 g) and incubated for 30 min at 37°C. After removal of free beads, the relative amount of ingested particles was quantified by flow cytometry and data were expressed as mean fluorescence intensity (MFI).
APC-NK cocultures
Untouched autologous NK-cells were separated using MACS NK Cell Isolation Kit II (Miltenyi, Germany) according to the instructions of the manufacturer. Isolated NK-cells were cryopreserved in 90% FCS and 10% DMSO until 24 h before use. DC and PFAPC generated for 3 or 7 days were cocultured with autologous NK cells in a ratio of 1:1 for 5 days. NK cell/APC cocultures were stimulated with BCG (MOI=1 based on complete cell count) or left untreated during the whole coculture period. After 5 days, the cells were harvested, the number of NK cells was counted using a CASY TT, and NK cells were then coincubated for 4-6 h with chromiumlabeled tumor cells (T24) at the indicated ratios. Indicated ratios are based on NK:tumor cell ratio. The amount of secreted IFN-γ in APC-NK cocultures on day 5 was determined by ELISA.
RESULTS
Morphology of monocytes cultured in the presence of PF-4 and IL-4
In our attempt to assess the function of PF-4 in the process of differentiation of APC, we first investigated the effect of PF-4/IL-4 stimulation on the morphological appearance of monocytes. Peripheral blood monocytes were stimulated with a combination of PF-4 and IL-4 for 2-3 days until first medium exchange. Culture was then continued with fresh medium and IL-4 supplementation while no further PF-4 was added. Morphology of PF-4/IL-4 differentiated monocytes was compared with morphology of classical immature DCs generated in the presence of GM-CSF and IL-4. In both cultures, morphological changes became apparent early after stimulation resulting in profound differences between GM-CSF/IL-4 and PF-4/IL-4 cultures on day 7 (Fig. 1) . PF-4/IL-4 differentiated monocytes were extremely adherent throughout the entire culture period, had a tendency to form larger cellular clusters, and showed irregular shape. Classical DCs appeared as typical loosely adherent cells with dendrite-like extrusions. Recovery of classical DC and PF-4/IL-4 differentiated cells was similar and typically in a range from 40 to 60% of the monocytes seeded on day 0. Control cultures with IL-4 alone resulted in monocyte apoptosis and low (~10-15%) cell recovery (not shown).
Cell surface phenotype of PF-4/IL-4-differentiated monocytes
After the microscopical examination had revealed significant morphological alterations of monocytes when exposed to PF-4 and IL-4, we next examined the cell phenotype by analyzing the expression of a set of well-defined surface markers. In a first series of experiments, we compared PF-4/IL-4-differentiated monocytes with three other monocyte-derived antigenpresenting cell populations: macrophages differentiated in the presence of GM-CSF (MΦ), macrophages differentiated in the presence of PF-4 (PF-MΦ), and DCs differentiated in the presence of GM-CSF and IL-4 (DC; Fig. 2A ). As APC are primary targets of invading microorganisms and as DC undergo maturation when encountering microbial challenge, we also assessed phenotypic changes after bacterial stimulation. For this purpose, we used Mycobacterium bovis BCG, which has been described to induce maturation of monocyte-derived DC (27, 28) .
Our flow cytometric analysis revealed that, as compared with classical GM-CSF differentiated macrophages, PF-4 stimulated macrophages displayed no expression of CD1a, increased expression of CD86, and reduced expression of MHC class II confirming previous observations (8) . Both macrophage populations shared the significant expression of CD14 and the lack of CD83 and CD209 (DC-SIGN). All cell populations tested expressed similar amounts of CD40 (not shown). Profound differences were observed between PF-MΦ and PF-4/IL-4 differentiated monocytes. In contrast to PF-MΦ, PF-4/IL-4 differentiated monocytes expressed CD1b/c and CD209 on their surface while CD14 was absent. Also, unlike PF-MΦ, PF-4/IL-4 differentiated monocytes up-regulated expression of CD83 after bacterial stimulation. Direct comparison of classical DC and PF-4/IL-4 differentiated monocytes revealed certain phenotypical similarities as both cell populations were CD14-/CD40+/CD209+/MHCII+. Upon stimulation with BCG, both cell populations up-regulated expression of CD83 and CD86 accompanied by CD209 downregulation. Similar phenotypic maturation of both cell types was also observed after stimulation with LPS (a bacterial TLR-4 ligand) and CD154 + IFN-γ (a T cell-derived stimulus) (data not shown). Besides these similarities, there were also clear differences between PF-4/IL-4 cells and DC, as CD1a was differentially expressed with PF-4/IL-4 differentiated monocytes lacking expression of this marker. Based on the differential expression of CD1a, we searched for other phenotypical differences and analyzed expression of BDCA1 (CD1c) and BDCA3, two recently described DC markers (29) . Interestingly, PF-4/IL-4 stimulated monocytes lacked expression of BDCA1 but abundantly expressed BDCA3, a marker so far only described on blood DCs (ref 30 ;  Fig. 2B ). In contrast, conventional DCs stained positive for BDCA1 but only minimally expressed BDCA3. It is important to note that on PF-4/IL-4 cells we observed a low constitutive expression of CD83 and CCR7 and an intermediate constitutive expression of CD86 even in the absence of bacterial stimulation. Constitutive expression of these markers was not detected on unstimulated conventional DCs ( Fig. 2A) . This may indicate that differentiation with PF-4 and IL-4 generated an antigen-presenting cell with some phenotypic properties of mature DCs in the absence of a typical maturation stimulus.
To further elucidate the role of PF-4 in APC differentiation, phenotypic changes of monocytes were monitored upon exposure of cells to increasing concentrations of PF-4 at a constant dose of IL-4. As depicted in Fig. 3 , we observed three major effects, which can be attributed to the concentration of PF-4 used. An increase of PF-4 concentration from 0.25 up to 4 µM led to a down-regulation of the expression of CD14, an up-regulation of CD83, and an increased capacity of bacterial stimuli (BCG) to induce CD83. These data show that PF-4 stimulation dosedependently affects phenotypic changes involved in differentiation and maturation of human APC.
To complete our phenotypical analysis of PF-4/IL-4 differentiated monocytes, we performed time kinetics and monitored changes in important surface molecules over a time course of 7 days (Fig. 4) . We found complete down-regulation of CD14 within 2-3 days of culture, whereas in conventional DC complete down-regulation was observed as late as day 7. Interestingly the PF-4 treated cells exhibited a constitutive and early expression of CD83 and CD86, which peaked between day 2 and day 4 of culture. Expression of both markers was down-regulated again during further differentiation. No expression of CD83 and CD86 was observed in conventionally generated DC.
Taken together, our initial experiments showed that PF-4/IL-4-induced differentiation of human monocytes is accompanied by morphologic changes as well as phenotypic changes. PF-4/IL-4-differentiated monocytes expressed considerable amounts of MHC class II and CD209 simultaneously lacking expression of CD14 and CD1a. Furthermore, they showed a rapid differentiation accompanied by rapid down-regulation of CD14 and simultaneous up-regulation of CD83 and CD86. Later in the differentiation process (day 4 to day 7) the expression of CD83 and CD86 is down-regulated again. Based on these phenotypes, PF-4/IL-4 differentiated monocytes are subsequently abbreviated as PFAPC (PF-4/IL-4 differentiated APC). It is important to note that PFAPC differed substantially from PF-4 differentiated macrophages as well as conventional DCs (Figs. 2 and 4) .
Cytokine release upon microbial stimulation
To further characterize PFAPC, we analyzed their ability to release cytokines after interaction with pathogen-associated (LPS and BCG) or cell-associated (CD154) stimuli. Based on the observations made in the time-kinetic study, we chose an early (d3) and a late (d7) time point in the differentiation process after which the cells were stimulated. The amount of TNF-α (proinflammatory), IL-12 (T-helper 1), and IL-10 (immunosuppressive, T-helper 2) secreted into the culture supernatants was determined by ELISA. As depicted in Fig. 5 , conventional DC responded with substantial release of all three cytokines after microbial challenge and CD40 ligation. In contrast, the overall cytokine response of PFAPC was reduced and only minimal IL-12 production after stimulation with BCG and LPS could be detected. Among the stimuli tested, ligation of CD40 generally induced stronger cytokine responses of PFAPC when compared with the microbial stimuli. Altogether these findings suggest a substantially reduced cytokine production by PFAPC.
Oxidative burst and phagocytic activity
Oxidative burst and phagocytosis are key features of myeloid cells and essential for pathogen elimination and antigen uptake. As shown in Fig. 6A , conventional DC and PFAPC had virtually no oxidative burst activity, while this activity was high in the respective macrophages. Thus, it appears that both DC and PFAPC have down-regulated an important cellular machinery required for killing of intracellular pathogens. Nevertheless, PFAPC and DC were still active phagocytes and effectively took up particulate material (Fig. 6B and C) . This phagocytic activity was, however, reduced compared with the respective macrophages. As expected, on day 7 phagocytic activity and the number of phagocytic conventional DCs decreased after LPS stimulation. Interestingly and conversely, this was not the case for PFAPC. Instead, phagocytosis by day 7 PFAPC was even slightly enhanced upon maturation (Fig. 6C ). This might suggest a different effect of the maturation signal on phagocytic activity between DC and PFAPC.
Induction of lymphocyte and NK responses by PFAPC
A characteristic feature of conventional DCs is their high stimulatory capacity in MLR reactions compared with monocytes and macrophages (31) . After analysis of morphology, phenotype, cytokine release, and phagocytosis, we next analyzed the lymphostimulatory properties of PFAPC in MLR and antigen-presentation assays. We performed a comparative analysis of DCs and PFAPCs generated from monocytes of the same donor. Based on our previous experiment, we again compared an early and late time point of the differentiation process.
As depicted in Fig. 7 , both PFAPC and DC were potent stimulators in MLR cultures. On day 3 of the differentiation process, PFAPC were equally effective as classical DC in stimulating lymphoproliferation. Obviously, when differentiated beyond day 3, PFAPC became less immunostimulatory and showed a somewhat reduced induction of proliferation in MLR cultures. A very similar picture was observed in antigen-presentation assays using TT as a recall antigen. On day 3 of differentiation, PFAPC are equivalent to conventional DC in inducing TT-specific lymphoproliferative responses. Again day 7 PFAPC are less immunostimulatory (Fig. 7B) . These data obtained for lymphoproliferation are contrasted by our data on the induced lymphocytic cytokine response. Interestingly, when we investigated the IFNγ response of lymphocytes in TT antigen-presentation assays, we observed a generally reduced stimulatory capacity of PFAPC. Both day 3 and day 7 PFAPC induced lower amounts of IFN-γ in response to TT presentation when compared with conventional DCs (Fig. 7C) . Thus, although on day 3 of the differentiation process PFAPC are fully comparable with DC with regard to induction of lymphoproliferation ( Fig. 7A and B) , these day 3 PFAPC are inferior to conventional DC in their capacity to induce lymphocytic cytokines. We conclude that on day 3 of the differentiation process PFAPC preferentially induce lymphoproliferation vs. cytokine release. Beyond day 3 of differentiation PFAPC exhibit a somewhat less immunostimulatory capacity.
Representing a link between innate and adaptive immunity, DCs cannot only activate T-cells but are also capable of interacting with NK cells. Thus, it has been recognized that the interaction of DCs and NK cells results in enhanced lytic NK activity (32) and this activity can be further induced by appropriate DC stimulation. We have tested the potential of DC and PFAPC differentiated for 3 (Fig. 8A) or 7 days (Fig. 8B ) to enhance lytic NK activity. Using a bladder tumor cell line largely resistent to the lysis by freshly isolated resting NK cells (note the low lytic activity of purified NK cells in the absence of APCs), we observed a clearly enhanced lysis when NK cells had been cocultured with both PFAPC and DC differentiated for 3 days (Fig. 8A ). This target cell lysis could be further enhanced when APCs were stimulated with BCG mycobacteria. Again day 7 PFAPC were somewhat less immunostimulatory compared with day 3 PFAPC. Intriguingly, although PFAPC were able to induce substantial cytolytic NK cell activity, in supernatants of NK-PFAPC cocultures only minimal amounts of IFNγ were detected (Fig. 8C  and D) . In sharp contrast, high amounts of IFN-γ were present in cocultures of classical DC and NK cells, especially after bacterial stimulation. These observations underscore the hypothesis that PFAPC efficiently activate certain lymphocyte and NK functions (proliferation, cytotoxicity), while others (IFN-γ production) are only marginally induced. In this regard, PFAPC represent a subtype of specialized human APC.
DISCUSSION
There is accumulating evidence suggesting an immunomodulatory function of platelets during inflammation and infection. It has been described that upon activation platelets secrete different chemokines (PF-4, β-TG, RANTES), cytokines (IL1-β), and immunomodulatory agents (CD154, P-selectin) and in this way interact with other leukocyte subpopulations (1). Therefore, it was of interest for us to analyze the effects of the major platelet-derived CXC-chemokine PF-4 on the function and differentiation of human APCs. We hypothesized that PF-4 in conjunction with IL-4 would induce differentiation of human peripheral blood monocytes. Indeed, we could show that culture of monocytes in the presence of PF-4 and IL-4 leads to the differentiation of monocytes into APCs. Based on our phenotypic and functional analysis, we termed these cells PFAPCs (PF-4/IL-4 differentiated APC). Monocyte to PFAPC differentiation was accompanied by rapid phenotypic and functional alterations. Although PFAPC also shared certain features with other human APC subpopulations, their phenotypical and functional analysis revealed that they were clearly distinct from conventional macrophages and DC. PFAPC were potent stimulators of lymphoproliferation and lytic NK activity while their capacity to produce cytokines and to induce lymphocytic and NK cytokine responses was diminished compared with conventional DCs.
Although structurally a CXC chemokine, PF-4 has some unusual features setting it apart from other members of the chemokine family. PF-4 exhibits no typical chemotactic activity on neutrophils or other leukocytes but rather induces secondary granule exocytosis of neutrophils upon costimulation with TNF-α (21). Furthermore, unlike other CXC-chemokines PF-4 not only affects neutrophils but also a wide range of other cell types including T-cells (6), NK cells, (7) and monocytes (8) . In previous studies, we could show that monocytes cultured in the presence of PF-4 alone undergo phenotypic changes suggesting a differentiation into macrophages. Interestingly, in these studies PF-4 primarily acted as a survival factor and inhibited spontaneous monocyte apoptosis (8) . Thus far, the functional consequences of this differentiation are unclear as functional studies on these PF-4 differentiated macrophages are not yet available. In this study, we have dissected the cooperative effects of PF-4 and IL-4 on the functional and phenotypical properties of APCs generated from monocyte precursors. Monocytes can readily be differentiated into conventional DCs by GM-CSF and IL-4 stimulation, and we used these wellcharacterized professional APCs as a reference to be able to better assess the functional properties of PFAPCs.
The stimulatory potential in MLR is a hallmark of DC function. PFAPC on day 3 of differentiation displayed a high stimulatory potential in allogeneic MLR and were clearly as potent as conventional DCs in stimulating lymphocyte proliferation (Fig. 7A) . Similarly, PFAPC on day 3 of differentiation were strong inducers of lymphocyte proliferation in a TT antigen presentation assay (Fig. 7B) . Thus, within 3 days PF-4 in conjunction with IL-4 induces the differentiation of monocytes into APCs that are comparable to conventional DCs with respect to their capacity to induce proliferation of allogeneic and autologous lymphocytes. On the other hand, it was also very clear that day 7 PFAPC were inferior to day 3 PFAPC in terms of induction of lymphoproliferation. This indicates that PFAPC might undergo some redifferentiation when cultured beyond day 3 or 4 and during this redifferentiation become less immunostimulatory (a topic which will be discussed in more detail below). Xia and Kao (33) differentiated human monocytes for 6 days in the presence of GM-CSF, IL-4, and PF-4 and observed a reduced stimulation of T cell proliferation compared with DCs generated in the absence of PF-4. In their study, no analysis at earlier time points was performed and it remains to be tested whether the strong induction of lymphoproliferation seen in our study is exclusive to PF-4/IL-4 stimulated APC or can also be obtained in the presence of additional GM-CSF.
Monocyte-derived DCs are potent inducers of T H 1 cytokine responses after encountering T-cellderived signals or certain bacterial danger signals (34) . However, depending on the culture conditions during differentiation or depending on the type of stimulus, monocyte-derived DCs might also induce type 2 responses (35) . The influence of cytokines during differentiation on the outcome of the cytokine response is best illustrated by the observation that human monocytes cultured in the presence of IL-3 and IL-4 differentiate into DCs that predominantly induce T H 2 responses (36). In our experiments, we have noted a reduced production of bioactive IL-12p70 by PFAPC (Fig. 5B ) and a reduced production of IFN-γ by primed lymphocytes (Fig. 7C ) and cocultured NK cells (Fig. 8C and D) . However, according to our data, the cytokine response provoked by PFAPC is not shifted toward T H 2 but rather is generally reduced. This is exemplified by the simultaneous reduction in IL-12, TNF, and IL-10 production of PFAPC (Fig.  5) and by the fact that we have been unable to detect measurable amounts of IL-4 in the lymphocyte cultures (data not shown).
Although still no DC-specific phenotypic markers exist, monocyte-derived DCs and blood DCs can be characterized by a typical combination of marker antigens. Thus, monocyte-derived DCs lack typical lineage markers including CD14, and they do express high levels of MHC class II together with costimulatory molecules like CD40 and the C-type lectin DC-SIGN (CD209). The newly described antigen BDCA3 (29) is absent or expressed at very low levels on monocytederived DCs, while CD1c (BDCA1) is abundantly expressed. Also monocyte-derived DCs are positive for CD1a if generated in the presence of FCS (Fig. 2) . When we compared the phenotype of these conventional monocyte-derived DCs with the phenotype of PFAPCs, several clear differences became apparent. PFAPCs showed a more pronounced down-regulation of CD14, a reduced expression of CD209, and a stronger expression of CD83, CD86, and CCR7, which were expressed by PFAPC even in the absence of microbial stimulation. Intriguingly, PFAPC were, in sharp contrast to DCs, negative for CD1a and CD1c (BDCA1). Thus, it appears that both GM-CSF and PF-4 are required to increase survival of monocytes that undergo apoptosis when cultured without cytokines or in the presence of IL-4 only. At the same time, we observed pronounced differences in the phenotype of classical DC and PFAPC suggesting that GM-CSF and PF-4 differentially affect the transition of monocytes into APC.
Interestingly, we observed strong expression of BDCA-3 on PFAPC. BDCA3 is a newly described antigen that so far has been described exclusively on blood DCs (29) . It defines a minor subset of human CD11c + blood DCs (30) and is induced on plasmacytoid blood DCs and CD11c + /CD1c
+ myeloid blood DC upon in vitro maturation (29) . Here we show for the first time that certain monocyte-derived APC express BDCA3 antigen. Thus far, the BDCA3 antigen has not been cloned and no function has been assigned to this molecule. We have identified culture conditions resulting in BDCA3 expression on differentiated human monocytes. This might further facilitate the functional analysis of the BDCA3-positive DC subset.
Another distinct difference between DC and PFAPC was the absence of CD1a on PFAPC. CD1a-negative monocyte-derived DCs have been described under the influence of several culture conditions including the use of Yssels medium (37) , the use of human plasma or serum instead of FCS (38, 39) , the addition of PF-4 together with GM-CSF and IL-4 (33) , and the differentiation with IL-3/IL-4 instead of GM-CSF/IL-4 (36) . It was noted in several of these studies that CD1a-negative DCs, in contrast to their CD1a-positive counterparts, changed the cytokine response from T H 1 toward T H 0/T H 2 (33, 36, 37) . We have differentiated our monocytes in the presence of RPMI, FCS, recombinant cytokines, and highly purified native PF-4 for the following reasons: 1) native PF-4 isolated by a previously described three-step purification protocol retains high biological activity but is essentially free of contaminating LPS or other platelet-derived chemokines (21); 2) FCS containing media ensured a high yield of APC (lower yield under serum-free conditions, unpublished observation); 3) we avoided human plasma or serum as this preparation contained undefined amounts of platelet-derived products; and 4) the APCs used in our in vitro study are not intended for clinical use and xenogeneic FCS antigens are therefore tolerable. Under these conditions, we have not observed a T H 1/T H 2 cytokine shift but rather a generally reduced cytokine production under the influence of PF-4.
Throughout our study there were significant differences between PFAPCs differentiated for 3 days and those differentiated for 7 days. Immediately after onset of differentiation, PFAPC rapidly changed their morphology, phenotype, and functional properties. Day 3 PFAPC were highly immunostimulatory and expressed significant amounts of activation markers (CD83 and CD86). After days 3-4, PFAPC down-regulated activation markers and became less responsive to microbial stimulation and less potent in stimulating lymphocytes and NK cells. However, at the same time they did not convert to monocytes (or macrophages), as they further developed their typical morphological features and maintained their DC-like phenotype and their reduced oxidative burst activity. No such changes in phenotype and function could be observed for conventional DCs, although it was obvious that day 3 DC already displayed a high immunostimulatory capacity -an aspect that has been somewhat underappreciated thus far and might deserve further clarification (40).
Short-term differentiation of DCs from monocyte precursors under the influence of inflammatory mediators has been rarely investigated (40) but might be relevant under physiological conditions and in vivo. Recent reports highlight the potential of murine and human blood monocytes to differentiate into DCs under inflammatory conditions (14, 15, 18) . IFN-α, reverse transendothelial migration, and short-term ex vivo culture can induce rapid monocyte to DC transition (16, 17, 41) . At the same time, platelets, by the production of CD154, can induce DC maturation and modulate adaptive immune responses (2) . Therefore, it was of interest for us to study the effects of the platelet-derived chemokine PF-4 on a possible monocyte to DC differentiation. Using a defined in vitro system, we indeed have identified a novel PF-4 dependent differentiation pathway of human monocytes. Further studies are needed to address the in vivo relevance of this monocyte differentiation process and a possible physiological role of such a pathway. If such APC exist at sites of platelet activation, these cells could, based on their specific functions, have regulatory functions in the acute phase as well as in the resolving phase of the inflammatory process.
Recent studies have described CD14-/collagen I+/CD34+/MHC class II+/CD86+ antigenpresenting fibrocytes in human peripheral blood (42) and suggested a possible role of these cells at sites of tissue injury. Together with the recent identification of CXCR3B as a functional receptor for PF-4 on endothelial cells (43) , the possibility existed that PF-4 by triggering CXCR3B on monocytes would induce differentiation of monocytes into fibrocytes or fibrocytelike cells. However, our own experiments strongly argue against this possibility as human peripheral blood monocytes do not express CXCR3B mRNA (44) and in vitro generated PFAPC were negative for collagen I and CD34, two distinct markers of native or in vitro generated fibrocytes (unpublished observation).
In conclusion, we have described a novel differentiation pathway of human monocytes that leads to the generation of specialized APC. It will be interesting to see whether a PFAPC counterpart exists at sites of platelet activation in vivo. Based on their specific functions, these specialized APC would be well equipped to serve regulatory functions in the acute phase as well as in the resolving phase of the inflammatory process. Monocytes were stimulated with GM-CSF (500 U/ml; GM), PF-4 (4 µM; PF4), PF-4/IL-4 (PF4/IL4) or GM-CSF/IL-4 (GM/IL4) in the absence (upper panels) or presence of logBCG (MOI=1; lower panels). Filled gray histograms represent isotype controls, black lined histograms the staining intensity of respective specific mAb. Monocytes were stimulated with cytokines for 7 days followed by a 3-day stimulation period with or without BCG. Data represent 1 representative experiment out of 6. B) Surface expression of BDCA1 and BDCA3 antigens on day 7 APC; 1 representative experiment out of 5 is shown. Monocytes were differentiated with GM-CSF (500 U/ml) or PF-4 (4 µM) in the presence of IL-4 (500 U/ml) for 3 or 7 days, respectively, followed by culture for 24 h in the absence or presence of BCG (MOI=1), LPS (10 ng/ml), or 3T3 fibroblasts expressing CD154. Supernatants were monitored for contents of TNFα (A), IL-10 (B), and IL-12 (C). Dark gray bars are cytokine release after 3 days and light gray bars the cytokine after 7 days of monocyte differentiation; 1 representative experiment out of 4 is shown. the presence of PF-4 (4 µM), GM-CSF (500 U/ml), PF-4 (4 µM)/IL-4 (500 U/ml), and GM-CSF (500 U/ml)/IL-4 (500 U/ml) for indicated time periods. Some wells were stimulated 24 h before assay with LPS (10 ng/ml). A) Oxidative burst of differentiated monocytes in relative light units (RLU) after uptake of latex beads. Black bars represent burst activity after 3 days and dark gray bars after 7 days of differentiation. 
